4//SEC Filing
Friedman Mark Louis 4
Accession 0000805928-22-000030
CIK 0000805928other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:06 PM ET
Size
14.2 KB
Accession
0000805928-22-000030
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Friedman Mark Louis
Vice President of RA/QA
Transactions
- Award
Employee Stock Option (right to purchase)
2022-03-16+33,419→ 33,419 totalExercise: $8.20Exp: 2032-03-16→ Common Stock (33,419 underlying) - Award
Restricted Stock Units
2022-03-16+35,829→ 35,829 total→ Common Stock (35,829 underlying) - Exercise/Conversion
Common Stock
2022-03-16+6,000→ 25,845 total - Exercise/Conversion
Restricted Stock Units
2022-03-16−6,000→ 6,000 totalFrom: 2024-03-16→ Common Stock (6,000 underlying) - Tax Payment
Common Stock
2022-03-16$7.97/sh−1,502$11,971→ 24,343 total
Footnotes (6)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2022.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F4]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F6]All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001531023
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:06 PM ET
- Size
- 14.2 KB